Skip to main content
Premium Trial:

Request an Annual Quote

Roche Joins Massachusetts Program to Support Early Stage LS Companies

NEW YORK (GenomeWeb) – The Massachusetts Life Sciences Center today said that Roche has joined the Center's Corporate Consortium Partners to support early stage life science firms in the state.

As a member, Roche will provide funding to support MLSC's investments in such businesses, and in return, Roche will have access to new technologies that may potentially lead to new healthcare solutions, MLSC said. According to an MLSC spokesperson, Roche will provide $250,000 to the consortium partner program.

Like other companies participating in the Corporate Consortium Partners program, Roche will have the chance to review the MLSC's "deal flow and to benefit from the assessments of that deal flow provided by the center's blue ribbon expert review panels," MLSC said.

Through its Accelerator Program, MLSC identifies early stage companies conducting promising translational science and research and makes loans available to them. The center also offers a Small Business Matching Grant program that matches federal Small Business Innovation Research and Small Business Technology Transfer grants. Corporate Consortium Partner members contribute matching funds for MLSC's investments, "maximizing support for the center's portfolio companies," the center said.

Details about Roche's funding contribution were not disclosed. The MLSC did not respond to a request for additional information.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.